| Pharmaceutical active ingredients: |
| Dipivefrin HydrochloridePilocarpine Hydrochloride |
| Available forms, composition and doses of Thiloadren N: |
| N / A |
| Thiloadren N medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| S01EA02 - DipivefrineS01EB51 - Pilocarpine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Alcon |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Thilodrin | Dipivefrin Hydrochloride | Alcon |
| Thilodigon | Dipivefrin Hydrochloride; Guanethidine Monosulfate | Alcon |
| Probeta | Dipivefrin Hydrochloride; Levobunolol Hydrochloride | Allergan |
| Thilocombin | Dipivefrin Hydrochloride; Pilocarpine | Alcon |
| Thiloadren | Dipivefrin Hydrochloride; Pilocarpine Hydrochloride | Alcon |
| Ryvina | Dipivefrin; Pilocarpine Hydrochloride | Rafarm |
| Pulmonarom | Diplococcus Pneumoniae; Haemophilus Influenzae; Klebsiella Pneumoniae; Moraxella Catarrhalis; Staphylococcus Aureus; Streptococcus Agalactiae; Streptococcus Anginosus; Streptococcus Dysgalactiae; Streptococcus Pyogenes | Sanofi-Aventis |
| Aerovacuna | Diplococcus; Gaffkya Anaerobia; Haemophilus Influenzae; Klebsiella Pneumoniae; Micrococcus Pyogenes; Moraxella; Neisseria; Streptococcus | Solvay |
| M50 | Diprenorphine Hydrochloride | Cyanamid |
| Remove | Dipropylene Glycol Methyl Ether | Smith & Nephew |